Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Botanix Pharmaceuticals Limited ( (AU:BOT) ) has provided an update.
Botanix Pharmaceuticals Limited has announced a proposed issue of 121,212,122 ordinary fully paid securities, with the issue date set for April 24, 2025. This move is part of a strategic effort to raise capital, potentially enhancing the company’s operational capabilities and market positioning, which could have significant implications for its stakeholders.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development and commercialization of dermatology and antimicrobial products. The company is known for its innovative approaches to skin health and treatment solutions, aiming to address unmet needs in the market.
YTD Price Performance: -19.32%
Average Trading Volume: 9,594,637
Technical Sentiment Signal: Hold
Current Market Cap: A$650.6M
See more data about BOT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue